These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29642144)

  • 1. Lectin microarray and mass spectrometric analysis of hepatitis C proteins reveals N-linked glycosylation.
    Guo Y; Yu H; Zhong Y; He Y; Qin X; Qin Y; Zhou Y; Zhang P; Zhang Y; Li Z; Jia Z
    Medicine (Baltimore); 2018 Apr; 97(15):e0208. PubMed ID: 29642144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of N-linked glycans in the interactions of recombinant HCV envelope glycoproteins with cellular receptors.
    Chen PC; Chuang PK; Chen CH; Chan YT; Chen JR; Lin SW; Ma C; Hsu TL; Wong CH
    ACS Chem Biol; 2014 Jul; 9(7):1437-43. PubMed ID: 24766301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of N-glycan expression profile and glycan pattern of glycoproteins in human hepatoma cells after HCV infection.
    Xiang T; Yang G; Liu X; Zhou Y; Fu Z; Lu F; Gu J; Taniguchi N; Tan Z; Chen X; Xie Y; Guan F; Zhang XL
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1036-1045. PubMed ID: 28229927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
    Akazawa D; Moriyama M; Yokokawa H; Omi N; Watanabe N; Date T; Morikawa K; Aizaki H; Ishii K; Kato T; Mochizuki H; Nakamura N; Wakita T
    Gastroenterology; 2013 Aug; 145(2):447-55.e1-4. PubMed ID: 23673355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
    Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
    Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu.
    Denolly S; Granier C; Fontaine N; Pozzetto B; Bourlet T; Guérin M; Cosset FL
    J Hepatol; 2019 Apr; 70(4):626-638. PubMed ID: 30553840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
    Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
    Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody.
    Cook MC; Kaldas SJ; Muradia G; Rosu-Myles M; Kunkel JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():162-78. PubMed ID: 26114652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Identification and Differential Distribution Analysis of Glycans in Subcellular Fractions of Bladder Cells.
    Yang G; Huang L; Zhang J; Yu H; Li Z; Guan F
    Int J Biol Sci; 2016; 12(7):799-811. PubMed ID: 27313494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization.
    Anjum S; Wahid A; Afzal MS; Albecka A; Alsaleh K; Ahmad T; Baumert TF; Wychowski C; Qadri I; Penin F; Dubuisson J
    J Infect Dis; 2013 Dec; 208(11):1888-97. PubMed ID: 23908491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric characterization of glycosylation of hepatitis C virus E2 envelope glycoprotein reveals extended microheterogeneity of N-glycans.
    Iacob RE; Perdivara I; Przybylski M; Tomer KB
    J Am Soc Mass Spectrom; 2008 Mar; 19(3):428-44. PubMed ID: 18187336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.
    Lavie M; Hanoulle X; Dubuisson J
    Front Immunol; 2018; 9():910. PubMed ID: 29755477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
    Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
    Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
    Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.
    Pietschmann T; Lohmann V; Kaul A; Krieger N; Rinck G; Rutter G; Strand D; Bartenschlager R
    J Virol; 2002 Apr; 76(8):4008-21. PubMed ID: 11907240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C.
    Bartolomé J; López-Alcorocho JM; Castillo I; Rodríguez-Iñigo E; Quiroga JA; Palacios R; Carreño V
    J Virol; 2007 Jul; 81(14):7710-5. PubMed ID: 17475654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.
    Schaefer EA; Meixiong J; Mark C; Deik A; Motola DL; Fusco D; Yang A; Brisac C; Salloum S; Lin W; Clish CB; Peng LF; Chung RT
    World J Gastroenterol; 2016 Dec; 22(45):9954-9965. PubMed ID: 28018102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of HCV particles from serum-free culture.
    Akazawa D; Morikawa K; Omi N; Takahashi H; Nakamura N; Mochizuki H; Date T; Ishii K; Suzuki T; Wakita T
    Vaccine; 2011 Jun; 29(29-30):4821-8. PubMed ID: 21550372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.